Estradiol and progesterone modify the effects of the serotonin reuptake transporter polymorphism on serotonergic responsivity to citalopram

Experimental and Clinical Psychopharmacology

Volumn 19, Issue 6, 2011, Pages 401-408

  Michopoulos, Vasiliki ^a   Berga, Sarah L ^b   Wilson, Mark E ^a  

^a EMORY UNIVERSITY   (United States)

^b EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Citalopram; Estradiol; Females; Progesterone; Serotonin transporter

Indexed keywords

CITALOPRAM; ESTRADIOL; PROGESTERONE; SEROTONIN TRANSPORTER;

ALLELE; ANIMAL EXPERIMENT; ANXIETY DISORDER; ARTICLE; CONTROLLED STUDY; DEPRESSION; DISEASE PREDISPOSITION; DRUG EFFICACY; ESTRADIOL BLOOD LEVEL; FEMALE; GENETIC POLYMORPHISM; GENETIC SUSCEPTIBILITY; GENETIC VARIABILITY; GENOTYPE; HORMONE ACTION; HORMONE SUBSTITUTION; NONHUMAN; PROGESTERONE BLOOD LEVEL; PROLACTIN BLOOD LEVEL; PROMOTER REGION; PROTEIN EXPRESSION; RHESUS MONKEY; SEROTONINERGIC SYSTEM; TREATMENT RESPONSE;

ALLELES; ANIMALS; CITALOPRAM; ESTRADIOL; FEMALE; GENOTYPE; MACACA MULATTA; POLYMORPHISM, GENETIC; PROGESTERONE; PROLACTIN; SEROTONIN PLASMA MEMBRANE TRANSPORT PROTEINS; SEROTONIN UPTAKE INHIBITORS;

EID: 83755163634     PISSN: 10641297     EISSN: 19362293     Source Type: Journal    
DOI: 10.1037/a0025008     Document Type: Article

References (59)

1. Agis-Balboa R.C., Pinna G., Zhubi A., Maloku E., Veldic M., Costa E., Guidotti A. Characterization of brain neurons that express enzymes mediating neurosteroid biosynthesis. Proceedings of the National Academy of Sciences of the United States of America 2006, 103:14602-14607. doi: 10.1073/pnas.0606544103.
2. Berga S.L., Mortola J.F., Girton L., Suh B., Laughlin G., Pham P., Yen S.S. Neuroendocrine aberrations in women with functional hypothalamic amenorrhea. Journal of Clinical Endocrinology and Metabolism 1989, 68:301-308. doi: 10.1210/jcem-68-2-301.
3. Bethea C.L., Lu N.Z., Gundlah C., Streicher J.M. Diverse actions of ovarian steroids in the serotonin neural system. Frontiers in Neuroendocrinology 2002, 23:41-100. doi: 10.1006/frne.2001.0225.
4. Caspi A., Sugden K., Moffitt T.E., Taylor A., Craig I.W., Harrington H., Poulton R. Influence of life stress on depression: Moderation by a polymorphism in the 5-HTT gene. Science 2003, 301:386-389. doi: 10.1126/science.1083968.
5. Centeno M.L., Reddy A.P., Smith L.J., Sanchez R.L., Henderson J.A., Salli N.C., Bethea C.L. Serotonin in microdialysate from the mediobasal hypothalamus increases after progesterone administration to estrogen primed macaques. European Journal of Pharmacology 2007, 555:67-75. doi: 10.1016/j.ejphar.2006.10.027.
6. Collura L.A., Hoffman J.B., Wilson M.E. Administration of human leptin differentially affects parameters of cortisol secretion in socially housed female rhesus monkeys. Endocrine 2009, doi: 10.1007/s12020-009-9250-7.
7. Dare G.L., de Castro M., Maciel L.M. Hypothalamic-pituitary axis and peripheral tissue responses to TRH stimulation and liothyronine suppression tests in normal subjects evaluated by current methods. Thyroid 2008, 18:401-409. doi: 10.1089/thy.2007.0237.
8. Drevets W.C., Frank E., Price J.C., Kupfer D.J., Holt D., Greer P.J., Mathis C. PET imaging of serotonin 1A receptor binding in depression. Biological Psychiatry 1999, 46:1375-1387. doi: 10.1016/S0006-3223(99)00189-4.
9. Egli M., Leeners B., Kruger T.H. Prolactin secretion patterns: Basic mechanisms and clinical implications for reproduction. Reproduction 2010, 140:643-654. doi: REP-10-0033[pii]10.1530/REP-10-0033.
10. Fabre V., Beaufour C., Evrard A., Rioux A., Hanoun N., Lesch K.P., Martres M.P. Altered expression and functions of serotonin 5-HT1A and 5-HT1B receptors in knock-out mice lacking the 5-HT transporter. European Journal of Neuroscience 2000, 12:2299-2310. doi: ejn126[pii].
11. Fitzgerald P., Dinan T.G. Prolactin and dopamine: What is the connection? A review article. Journal of Psychopharmacology 2008, 22:12-19. doi: 22/2_suppl/12[pii]10.1177/0269216307087148.
12. Gao B., Fritschy J.M., Benke D., Mohler H. Neuron-specific expression of GABAA-receptor subtypes: Differential association of the alpha 1- and alpha 3-subunits with serotonergic and GABAergic neurons. Neuroscience 1993, 54:881-892. doi: 0306-4522(93)90582-Z[pii].
13. Gingrich J.A., Hen R. Dissecting the role of the serotonin system in neuropsychiatric disorders using knockout mice. Psychopharmacology (Berl) 2001, 155:1-10. doi: 10.1007/s002130000573.
14. Grattan D.R., Kokay I.C. Prolactin: A pleiotropic neuroendocrine hormone. Journal of Neuroendocrinology 2008, 20:752-763. doi: JNE1736[pii]10.1111/j.1365-2826.2008.01736.x.
15. Heils A., Mossner R., Lesch K.P. The human serotonin transporter gene polymorphism-basic research and clinical implications. Journal of Neural Transmission 1997, 104:1005-1014. doi: 10.1007/BF01273314.
16. Higley J.D., Thompson W.W., Champoux M., Goldman D., Hasert M.F., Kraemer G.W., Linnoila M. Paternal and maternal genetic and environmental contributions to cerebrospinal fluid monoamine metabolites in rhesus monkeys (Macaca mulatta). Archives of General Psychiatry 1993, 50:615-623.
17. Hoffman J.B., Kaplan J.R., Kinkead B., Berga S.L., Wilson M.E. Metabolic and reproductive consequences of the serotonin transporter promoter polymorphism (5-HTTLPR) in the adult female rhesus macaque (Macaca mulatta). Endocrine 2007, 31:202-211. doi: 10.1007/s12020-007-0017-8.
18. Jarrell H., Hoffman J.B., Kaplan J.R., Berga S., Kinkead B., Wilson M.E. Polymorphisms in the serotonin reuptake transporter gene modify the consequences of social status on metabolic health in female rhesus monkeys. Physiology and Behavior 2008, 93:807-819. doi: 10.1016/j.physbeh.2007.11.042.
19. Katznelson L., Riskind P.N., Saxe V.C., Klibanski A. Prolactin pulsatile characteristics in postmenopausal women. Journal of Clinical Endocrinology and Metabolism 1998, 83:761-764. doi: 10.1210/jc.83.3.761.
20. Koldzic-Zivanovic N., Seitz P.K., Watson C.S., Cunningham K.A., Thomas M.L. Intracellular signaling involved in estrogen regulation of serotonin reuptake. Molecular Cell Endocrinology 2004, 226:33-42. doi: 10.1016/j.mce.2004.07.017.
21. Kraft J.B., Peters E.J., Slager S.L., Jenkins G.D., Reinalda M.S., McGrath P.J., Hamilton S.P. Analysis of association between the serotonin transporter and antidepressant response in a large clinical sample. Biological Psychiatry 2007, 61:734-742. doi: S0006-3223(06)00941-3[pii]10.1016/j.biopsych.2006.07.017.
22. Lesch K.P., Bengel D., Heils A., Sabol S.Z., Greenberg B.D., Petri S., Murphy D.L. Association of anxiety-related traits with a polymorphism in the serotonin transporter gene regulatory region. Science 1996, 274:1527-1531. doi: 10.1126/science.274.5292.1527.
23. Lesch K.P., Meyer J., Glatz K., Flugge G., Hinney A., Hebebrand J., Heils A. The 5-HT transporter gene-linked polymorphic region (5-HTTLPR) in evolutionary perspective: Alternative biallelic variation in rhesus monkeys. Rapid communication. Journal of Neural Transmission 1997, 104:1259-1266. doi: 10.1007/BF01294726.
24. Lopez J.F., Chalmers D.T., Little K.Y., Watson S.J. A. E. Bennett Research Award. Regulation of serotonin1A, glucocorticoid, and mineralocorticoid receptor in rat and human hippocampus: Implications for the neurobiology of depression. Biological Psychiatry 1998, 43:547-573. doi: S0006322397004848[pii].
25. Lotrich F.E., Pollock B.G., Ferrell R.E. Polymorphism of the serotonin transporter: Implications for the use of selective serotonin reuptake inhibitors. Am J Pharmacogenomics 2001, 1:153-164. doi: 010301[pii].
26. Lotrich F.E., Pollock B.G., Kirshner M., Ferrell R.F., Reynolds C.F. Serotonin transporter genotype interacts with paroxetine plasma levels to influence depression treatment response in geriatric patients. Journal of Psychiatry and Neuroscience 2008, 33:123-130.
27. Lucki I. The spectrum of behaviors influenced by serotonin. Biological Psychiatry 1998, 44:151-162. doi: 10.1016/S0006-3223(98)00139-5.
28. Majewska M.D., Harrison N.L., Schwartz R.D., Barker J.L., Paul S.M. Steroid hormone metabolites are barbiturate-like modulators of the GABA receptor. Science 1986, 232:1004-1007. doi: 10.1126/science.2422758.
29. Manuck S.B., Bleil M.E., Petersen K.L., Flory J.D., Mann J.J., Ferrell R.E., Muldoon M.F. The socio-economic status of communities predicts variation in brain serotonergic responsivity. Psychological Medicine 2005, 35:519-528. doi: 10.1017/S0033291704003757.
30. Matsushita N., Kato Y., Shimatsu A., Katakami H., Yanaihara N., Imura H. Effects of VIP, TRH, GABA and dopamine on prolactin release from superfused rat anterior pituitary cells. Life Sciences 1983, 32:1263-1269. doi: 10.1016/0024-3205(83)90196-0.
31. McEwen B.S. Invited review: Estrogens effects on the brain: Multiple sites and molecular mechanisms. Journal of Applied Physiology 2001, 91:2785-2801.
32. McQueen J.K., Wilson H., Sumner B.E., Fink G. Serotonin transporter (SERT) mRNA and binding site densities in male rat brain affected by sex steroids. Brain Research. Molecular Brain Research 1999, 63:241-247. doi: S0169328X98002812[pii].
33. Michopoulos V., Wilson M.E. Body weight decreases induced by estradiol in female rhesus monkeys are dependent upon social status. Physiology and Behavior 2011, 102:382-388. doi: S0031-9384(10)00431-2[pii]10.1016/j.physbeh.2010.11.031.
34. Murphy G.M., Hollander S.B., Rodrigues H.E., Kremer C., Schatzberg A.F. Effects of the serotonin transporter gene promoter polymorphism on mirtazapine and paroxetine efficacy and adverse events in geriatric major depression. Archives of General Psychiatry 2004, 61:1163-1169. doi: 61/11/1163[pii]10.1001/archpsyc.61.11.1163.
35. Nemeroff C.B., Widerlov E., Bissette G., Walleus H., Karlsson I., Eklund K., Vale W. Elevated concentrations of CSF corticotropin-releasing factor-like immunoreactivity in depressed patients. Science 1984, 226:1342-1344. doi: 10.1126/science.6334362.
36. Pazol K., Kaplan J.R., Abbott D.H., Wilson M.E. Practical Measurement of total and bioavailable estradiol in female macaques. Clinica Chimica Acta 2004, 340:117-126. doi: 10.1016/j.cccn.2003.10.010.
37. Pecins-Thompson M., Bethea C.L. RU 486 blocks and fluoxetine augments progesterone-induced prolactin secretion in monkeys. Neuroendocrinology 1997, 65:335-343. doi: 10.1159/000127192.
38. Pecins-Thompson M., Brown N.A., Bethea C.L. Regulation of serotonin re-uptake transporter mRNA expression by ovarian steroids in rhesus macaques. Brain Research. Molecular Brain Research 1998, 53:120-129. doi: 10.1016/S0169-328X(97)00286-6.
39. Pfaff D.W., Vasudevan N., Kia H.K., Zhu Y.S., Chan J., Garey J., Ogawa S. Estrogens, brain and behavior: Studies in fundamental neurobiology and observations related to women's health. Journal of Steroid Biochemistry & Molecular Biology 2000, 74:365-373. doi: 10.1016/S0960-0760(00)00114-X.
40. Reist C., Mazzanti C., Vu R., Tran D., Goldman D. Serotonin transporter promoter polymorphism is associated with attenuated prolactin response to fenfluramine. American Journal of Medicine Genetics 2001, 105:363-368. doi: 10.1002/ajmg.1360[pii].
41. Romano G.J., Krust A., Pfaff D.W. Expression and estrogen regulation of progesterone receptor mRNA in neurons of the mediobasal hypothalamus: An in situ hybridization study. Molecular Endocrinology 1989, 3:1295-1300. doi: 10.1210/mend-3-8-1295.
42. Rubinow D.R., Schmidt P.J., Roca C.A. Estrogen-serotonin interactions: Implications for affective regulation. Biological Psychiatry 1998, 44:839-850. doi: 10.1016/S0006-3223(98)00162-0.
43. Sheng Z., Kawano J., Yanai A., Fujinaga R., Tanaka M., Watanabe Y., Shinoda K. Expression of estrogen receptors (alpha, beta) and androgen receptor in serotonin neurons of the rat and mouse dorsal raphe nuclei; sex and species differences. Neuroscience Research 2004, 49:185-196. doi: 10.1016/j.neures.2004.02.011S0168010204000379[pii].
44. Smith G.S., Lotrich F.E., Malhotra A.K., Lee A.T., Ma Y., Kramer E., Pollock B.G. Effects of serotonin transporter promoter polymorphisms on serotonin function. Neuropsychopharmacology 2004, 29:2226-2234. doi: 10.1038/sj.npp.13005521300552[pii].
45. Sobrinho L.G. Prolactin, psychological stress and environment in humans: Adaptation and maladaptation. Pituitary 2003, 6:35-39. doi: 10.1023/A:1026229810876.
46. Stoffel-Wagner B. Neurosteroid biosynthesis in the human brain and its clinical implications. Annals of the New York Academy of Sciences 2003, 1007:64-78. doi: 10.1196/annals.1286.007.
47. Sumner B.E., Grant K.E., Rosie R., Hegele-Hartung C., Fritzemeier K.H., Fink G. Effects of tamoxifen on serotonin transporter and 5-hydroxytryptamine(2A) receptor binding sites and mRNA levels in the brain of ovariectomized rats with or without acute estradiol replacement. Brain Research. Molecular Brain Research 1999, 73:119-128. doi: 10.1016/S0169-328X(99)00243-0.
48. Sumner B.E., Grant K.E., Rosie R., Hegele-Hartung C., Fritzemeier K.H., Fink G. Raloxifene blocks estradiol induction of the serotonin transporter and 5-hydroxytryptamine2A receptor in female rat brain. Neuroscience Letters 2007, 417:95-99. doi: 10.1016/j.neulet.2007.02.039.
49. Swann A.C. Neuroreceptor mechanisms of aggression and its treatment. Journal of Clinical Psychiatry 2003, 64:26-35.
50. Twyman R.E., Macdonald R.L. Neurosteroid regulation of GABAA receptor single-channel kinetic properties of mouse spinal cord neurons in culture. Journal of Physiology 1992, 456:215-245.
51. Walker M.L., Gordon T.P., Wilson M.E. Reproductive performance in capture-acclimated female rhesus monkeys (Macaca mulatta). Journal of Medicine Primatology 1982, 11:291-302.
52. Walker M.L., Wilson M.E., Gordon T.P. Endocrine control of the seasonal occurrence of ovulation in rhesus monkeys housed outdoors. Endocrinology 1984, 114:1074-1081. doi: 10.1210/endo-114-4-1074.
53. Wallen K. Desire and ability: Hormones and the regulation of female sexual behavior. Neuroscience and Biobehavioral Reviews 1990, 14:233-241. doi: 10.1016/S0149-7634(05)80223-4.
54. Wallen K., Winston L.A., Gaventa S., Davis-DaSilva M., Collins D.C. Periovulatory changes in female sexual behavior and patterns of ovarian steroid secretion in group-living rhesus monkeys. Hormones and Behavior 1984, 18:431-450. doi: 10.1016/0018-506X(84)90028-X.
55. Weissman M.M., Olfson M. Depression in women: Implications for health care research. Science 1995, 269:799-801. doi: 10.1126/science.7638596.
56. Whale R., Quested D.J., Laver D., Harrison P.J., Cowen P.J. Serotonin transporter (5-HTT) promoter genotype may influence the prolactin response to clomipramine. Psychopharmacology (Berl) 2000, 150:120-122. doi: 10.1007/s002130000432.
57. Williams R.F., Gianfortoni J.G., Hodgen G.D. Hyperprolactinemia induced by an estrogen-progesterone synergy: Quantitative and temporal effects of estrogen priming in monkeys. Journal of Clinical Endocrinology and Metabolism 1985, 60:126-132. doi: 10.1210/jcem-60-1-126.
58. Wilson M.E., Fisher J., Chikazawa K., Yoda R., Legendre A., Mook D., Gould K.G. Leptin administration increases nocturnal concentrations of luteinizing hormone and growth hormone in juvenile female rhesus monkeys. Journal of Clinical Endocrinology and Metabolism 2003, 88:4874-4883. doi: 10.1210/jc.2003-030782.
59. Wilson M.E., Gordon T.P., Collins D.C. Serum 17 beta-estradiol and progesterone associated with mating behavior during early pregnancy in female rhesus monkeys. Hormones and Behavior 1982, 16:94-106. doi: 10.1016/0018-506X(82)90010-1.